This page includes the latest FDA filings for Boston Analytical. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.
Device Company | Device | Date |
---|---|---|
Ipsen Biopharmaceuticals, Inc., Ipsen Bioscience, Inc, ScinoPharm Taiwan Ltd., Hubei Haosun Pharmaceuticals Co. Ltd, Ipsen Pharma Biotech, Boston Analytical, Quality Chemical Laboratories (QCL), Avista | Prescription Medication | 2024-06-21 |
Ipsen Biopharmaceuticals, Inc., Ipsen Bioscience, Inc, ScinoPharm Taiwan Ltd., Hubei Haosun Pharmaceuticals Co. Ltd, Ipsen Pharma Biotech, Boston Analytical, Quality Chemical Laboratories (QCL), Avista | Prescription Medication | 2024-02-17 |
Ipsen Biopharmaceuticals, Inc., Ipsen Bioscience, Inc, ScinoPharm Taiwan Ltd., Hubei Haosun Pharmaceuticals Co. Ltd, Ipsen Pharma Biotech, Boston Analytical, Quality Chemical Laboratories (QCL), Avista | Prescription Medication | 2023-10-17 |
Ipsen Biopharmaceuticals, Inc., Ipsen Bioscience, Inc, ScinoPharm Taiwan Ltd., Hubei Haosun Pharmaceuticals Co. Ltd, Ipsen Pharma Biotech, Boston Analytical, Quality Chemical Laboratories (QCL), Avista | Prescription Medication | 2023-02-17 |
Ipsen Biopharmaceuticals, Inc., Ipsen Bioscience, Inc, ScinoPharm Taiwan Ltd., Hubei Haosun Pharmaceuticals Co. Ltd, Ipsen Pharma Biotech, Boston Analytical, Quality Chemical Laboratories (QCL), Avista | Prescription Medication | 2020-12-12 |
Ipsen Biopharmaceuticals, Inc., Ipsen Bioscience, Inc, ScinoPharm Taiwan Ltd., Hubei Haosun Pharmaceuticals Co. Ltd, Ipsen Pharma Biotech, Boston Analytical, Quality Chemical Laboratories (QCL), Avista | Prescription Medication | 2017-10-21 |